Psilocybin-Assisted Therapy Shows Long-Lasting Benefits for Depression
A groundbreaking study published in 2023 has revealed promising long-term results for psilocybin-assisted therapy in treating depression. Conducted jointly by Ohio State University and Johns Hopkins University, the study found significant and sustained improvements in participants' mental health five years post-treatment. The study involved 18 volunteers who received psilocybin in a therapeutic setting designed for introspection back in 2019. The treatment process consisted of 13 hours of therapeutic guidance, with participants receiving two doses of psilocybin two weeks apart. Participants reported a range of positive changes, including increased empathy, gratitude, self-acceptance, and confidence. They also developed a new ability to manage difficult emotions. These improvements led to significant reductions in depression, anxiety, and functional impairment, with 67% of participants remaining in remission from major depressive disorder five years later. Psilocybin may alter the relationship people have with their thoughts, triggering positive behavioral feedback loops that reinforce mental health. However, it's important to note that 11 participants did seek additional therapy or use antidepressants after the study, although no severe side effects were reported. The study's findings suggest that psilocybin-assisted therapy could be a promising treatment option for depression, with long-lasting positive effects. Further research is needed to fully understand and validate these results. The specific authors of the study are not identified in the provided search results.
Read also:
- Is it advisable to utilize your personal health insurance in a publicly-funded medical facility?
- Dietary strategies for IBS elimination: Aims and execution methods
- Benefits, suitable dosage, and safety considerations for utilizing pumpkin seed oil in treating an overactive bladder
- Harmful Medical Remedies: A Misguided Approach to Healing
